Amy Barone

United States Food and Drug Administration

Also affiliated with Center for Drug Evaluation and Research, Johns Hopkins University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trials”.

Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trials

Neuro-Oncology(2020)10.1093/neuonc/noaa253

N/A

0DataRank · unranked

19 citations

Matthew S. Brown, Jerrold L. Boxerman, Elizabeth R. Gerstner, Timothy J. Kaufmann, Patricia E. Cole +10 more

FDA Approval Summary: Cabozantinib for Differentiated Thyroid Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0873

N/A

0DataRank · unranked

48 citations

Amy Barone, Somak Chatterjee, Pallavi S. Mishra‐Kalyani, Yuan Li Shen, Emasenyie Isikwei +14 more

FDA Approval Summary: Vorasidenib for IDH -Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-1333

N/A

0DataRank · unranked

12 citations

Amy Barone, Stephanie Aungst, Claudia P. Miller, Suryatheja Ananthula, Youwei Bi +20 more